809 — Global Bio-chem Technology Co Share Price
- HK$801.67m
- HK$5.11bn
- HK$1.37bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.58 | ||
EV to EBITDA | 1.16 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | 323.99% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 4,561.39 | 848.87 | 746.55 | 12.71 | 1,373.94 | n/a | n/a | -24.65% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Global Bio-chem Technology Group Company Limited is an investment holding company principally engaged in the manufacture and sales of biochemical products. The Corn Sweeteners segment is engaged in the manufacture and sales of corn-based sweeteners products, including glucose, maltose, high fructose corn syrup, crystallized glucose and maltodextrin. The Polyol Chemicals segment is engaged in the manufacture and sales of corn-based biochemical products, including polyol chemicals, anti-freeze products, hydrogen and ammonia. The Amino Acids segment is engaged in the manufacture and sales of corn-based amino acids products, including lysine and threonine. The Upstream Products segment is engaged in the manufacture and sales of corn starch, gluten meal, corn oil and other corn refined products.
Directors
- Zihua Zhang CHM (50)
- Lalin Zhu DCE (52)
- Shuhang Liu EDR (46)
- Dehui Wang OTH (46)
- Vicky Yu OTH (37)
- Xiuzhen Zhang OTH (70)
- Sing Fai Chan SEC (36)
- Dongsheng Gao NED (51)
- Hongxia Dong NID (34)
- Kwok Pong Ng NID (43)
- Kit Lam Yeung NID (52)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 4th, 1999
- Public Since
- March 16th, 2001
- No. of Employees
- 2,154
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 8,907,405,717
- Address
- Unit 1104, Tower 1,Admrlty Ctr
- Web
- http://www.globalbiochem.com
- Phone
- +852 null28388155
- Auditors
- Mazars CPA Limited
Upcoming Events for 809
Similar to 809
Asian Citrus Holdings
Stock Exchange of Hong Kong Limited
Ausnutria Dairy
Stock Exchange of Hong Kong Limited
AustAsia
Stock Exchange of Hong Kong Limited
Besunyen Holdings Co
Stock Exchange of Hong Kong Limited
Chaoda Modern Agriculture (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:09 UTC, shares in Global Bio-chem Technology Co are trading at HK$0.09. This share price information is delayed by 15 minutes.
Shares in Global Bio-chem Technology Co last closed at HK$0.09 and the price had moved by -28.57% over the past 365 days. In terms of relative price strength the Global Bio-chem Technology Co share price has underperformed the FTSE Developed Asia Pacific Index by -25.44% over the past year.
There is no consensus recommendation for this security.
Global Bio-chem Technology Co does not currently pay a dividend.
Global Bio-chem Technology Co does not currently pay a dividend.
Global Bio-chem Technology Co does not currently pay a dividend.
To buy shares in Global Bio-chem Technology Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.09, shares in Global Bio-chem Technology Co had a market capitalisation of HK$801.67m.
Here are the trading details for Global Bio-chem Technology Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 809
Based on an overall assessment of its quality, value and momentum Global Bio-chem Technology Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Global Bio-chem Technology Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +17.88%.
As of the last closing price of HK$0.09, shares in Global Bio-chem Technology Co were trading +7.1% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Global Bio-chem Technology Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Global Bio-chem Technology Co's management team is headed by:
- Zihua Zhang - CHM
- Lalin Zhu - DCE
- Shuhang Liu - EDR
- Dehui Wang - OTH
- Vicky Yu - OTH
- Xiuzhen Zhang - OTH
- Sing Fai Chan - SEC
- Dongsheng Gao - NED
- Hongxia Dong - NID
- Kwok Pong Ng - NID
- Kit Lam Yeung - NID